Lupin Beats Vertex's Patent Suit Over Cystic Fibrosis Drug
A Delaware federal court has rejected Vertex Pharmaceuticals Inc.'s suit accusing Lupin Ltd. of infringing patents covering a cystic fibrosis treatment, with a judge saying Monday that Lupin's planned generic doesn't...To view the full article, register now.
Already a subscriber? Click here to view full article